Cargando…

Impact of donor vaccination on recipient response to early SARS-CoV-2 mRNA vaccination after allogeneic HSCT

Detalles Bibliográficos
Autores principales:	Leclerc, Mathieu, Redjoul, Rabah, Le Bouter, Anne, Beckerich, Florence, Robin, Christine, Parinet, Vincent, Pautas, Cécile, Menouche, Dehbia, Bouledroua, Selwa, Roy, Lydia, Cabanne, Ludovic, Nait-Sidenas, Yakout, Harfouch, Elham, Gautier, Eric, Fourati, Slim, Maury, Sébastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975260/ https://www.ncbi.nlm.nih.gov/pubmed/35378072 http://dx.doi.org/10.1016/S2352-3026(22)00097-7

Ejemplares similares

Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
por: Leclerc, Mathieu, et al.
Publicado: (2022)

Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT
por: Redjoul, Rabah, et al.
Publicado: (2021)

Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
por: Redjoul, Rabah, et al.
Publicado: (2021)

Breakthrough Covid‐19 infections in vaccinated recipients of allogeneic stem cell transplantation
por: Fourati, Slim, et al.
Publicado: (2022)

Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors
por: Leclerc, Mathieu, et al.
Publicado: (2021)

Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients
por: Robin, Christine, et al.
Publicado: (2017)

A rationale to prioritise vaccination of HSCT patients against COVID-19
por: Leclerc, Mathieu, et al.
Publicado: (2021)

Third Early “Booster” Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses
por: Ahmed-Belkacem, Abdelhakim, et al.
Publicado: (2022)

Molecular Demonstration of a Pneumocystis Outbreak in Stem Cell Transplant Patients: Evidence for Transmission in the Daycare Center
por: Robin, Christine, et al.
Publicado: (2017)

Divergent CD4(+) T-cell profiles are associated with anti-HLA alloimmunization status in platelet-transfused AML patients
por: Khelfa, Mehdi, et al.
Publicado: (2023)

Risk Factors and Scoring System for Predicting Bacterial Resistance to Cefepime as Used Empirically in Haematology Wards
por: El Maaroufi, Hicham, et al.
Publicado: (2015)

Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease
por: Spilleboudt, Chloé, et al.
Publicado: (2021)

Dentistry consensus on HSCT – Part III: Special topics – Dentistry on HSCT
por: Santos, Paulo Sérgio da Silva, et al.
Publicado: (2023)

Dental consensus on HSCT – Part II: dental Care during HSCT
por: Gobbi, Marcella Ferreira, et al.
Publicado: (2023)

Antibody Response to 2-Dose Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients
por: Maillard, Alexis, et al.
Publicado: (2021)

Near-Infrared Spectroscopy Demonstrates the Benefit of Erythracytapheresis in Sickle Cell Disease Adult Patients with Cerebral Vasculopathy
por: Martino, Suella, et al.
Publicado: (2023)

Neutropenia Secondary to SARS-Cov2 Vaccination in Post-Hematopoietic Stem Cell Transplant (HSCT) Patients
por: Juárez-Salcedo, LM, et al.
Publicado: (2023)

Pulmonary Complications Associated with HSCT
por: Kapadia, Malika, et al.
Publicado: (2017)

Immunogenicity of Inactivated Varicella Zoster Vaccine (ZV(IN)) in Autologous Hematopoietic Stem Cell Transplant (auto-HSCT) Recipients
por: Boeckh, Michael, et al.
Publicado: (2017)

Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies
por: Gressens, Simon B., et al.
Publicado: (2022)

Establishing the hematopoietic stem cell transplant (HSCT) in a developing country; the journey of HSCT in Semarang, Indonesia
por: Santosa, Damai, et al.
Publicado: (2020)

2487. Vaccination Rates in Post-Transplant Hematopoietic Stem Cell Transplant (HSCT) Patients: Where Do We Stand?
por: Ahmad, Hiba, et al.
Publicado: (2018)

Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis
por: Ge, Chenghao, et al.
Publicado: (2022)

1073. SARS-CoV-2 Vaccine-Induced Immunogenicity among Hematopoietic Stem Cell Transplant Recipients (HSCT)
por: Kokogho, Afoke, et al.
Publicado: (2022)

TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation
por: Moatti, Audrey, et al.
Publicado: (2022)

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
por: Maillard, Alexis, et al.
Publicado: (2022)

HSCT: Therapie und Prophylaxe von Komplikationen
por: Sonnet, Miriam
Publicado: (2022)

Predicting reversed-phase liquid chromatographic retention times of pesticides by deep neural networks
por: Parinet, Julien
Publicado: (2021)

COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future
por: Hall, Victoria G, et al.
Publicado: (2023)

Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination
por: Fourati, Slim, et al.
Publicado: (2016)

GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial
por: Ho, Vincent T., et al.
Publicado: (2022)

Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity
por: Einarsdottir, Sigrun, et al.
Publicado: (2022)

Magneto-Optical Nanostructures for Viral Sensing
por: Szunerits, Sabine, et al.
Publicado: (2020)

PW03-021 - HSCT in mevalonate kinase deficiency
por: Wolska-Kuśnierz, B, et al.
Publicado: (2013)

Biological and Genetic Aspects of Donor-Recipient Matching in HSCT
por: Lange, Andrzej, et al.
Publicado: (2012)

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications
por: Reis, Monica, et al.
Publicado: (2016)

Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies
por: Morris, Emma C., et al.
Publicado: (2019)

Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome
por: Greco, Raffaella, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients
por: Machado, Clarisse MARTINS, et al.
Publicado: (2020)

Fusarium infection manifesting as toe cellulitis in HSCT recipient
por: Malkiel, Sarah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uc6cq6qaaf5p67n32d7lsgqe5n